• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Machine learning platform guides pancreatic cyst management in patients

Bioengineer by Bioengineer
July 17, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: S. Springer et al., Science Translational Medicine (2019)

Researchers have created a comprehensive test based on machine learning algorithms to better guide the management of patients with pancreatic cysts – a potential precursor of pancreatic cancer. The new assay, called CompCyst, outperformed the current gold standard-of-care in an international, multicenter study of 875 patients. Crucially, the test would have avoided surgery in 60% of patients who underwent unnecessary surgical removal, suggesting its use could lead to fewer unneeded surgeries and lower health and economic costs. Pancreatic cysts are fluid-filled lesions in the pancreas that are found in up to 8% of all people over the age of 70. Although most cysts are benign, some pancreatic cysts that produce mucin can transform into an aggressive form of pancreatic cancer. What’s more, it is difficult to distinguish precancerous cysts from benign ones, so noncancerous cysts are often misclassified and unnecessarily removed with pancreatic surgery. To overcome this dilemma, Simeon Springer and colleagues enrolled 875 patients with pancreatic cysts and collected information of the mutations, proteins, and other markers linked to their either benign or mucin-producing cysts. They used deep learning techniques to train CompCyst to read these markers and classify patients into those that should be monitored, not monitored, or receive surgery. After training the test protocol with 436 of the original patients, the researchers found the test largely outperformed standard-of-care pathology when evaluated in 426 other patients: it correctly identified 60.4% of patients who should have been discharged (versus 18.9% using standard-of-care diagnosis), 48.6% of patients that should have been monitored (versus 34.3%), and 90.8% of patients in need of surgery (versus 88.8%). Future work will be necessary to prospectively validate the markers used in the test, but Springer et al. say their platform has strong potential to be used in the clinic as a complement to existing approaches.

###

Media Contact
Science Press Package Team
[email protected]

Related Journal Article

http://dx.doi.org/10.1126/scitranslmed.aav4772

Tags: cancerGeneticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

MRI Radiomics and Tumor Microenvironment in Cervical Cancer

September 2, 2025

New Study Highlights Global Disparities in Cancer Research Funding

September 2, 2025

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

September 1, 2025

Evaluating Diffuse Large B-Cell Lymphoma in Chinese Youth

September 1, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Culturally Tailored Tools for Early Eating Disorder Detection

Assessing Clonal Fidelity in Pterocarpus Marsupium Plantlets

MRI Radiomics and Tumor Microenvironment in Cervical Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.